Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim;

Mineralcorticoid receptor blockers in chronic kidney disease Sara Erraez; Manuel López-Mesa; Pablo Gómez-Fernández;

Increased serum phosphate concentration within the normal reference levels is associated with all-cause mortality in non-dialysis CKD patients: A five-year prospective cohort study Ana Cerqueira; Janete Quelhas-Santos; Núria Paulo; Claúdia Camila Dias; Manuel Pestana;